Highlight 
Type Public (SIX: NOVN, NYSE: NVS) Founded 1996 (from merger) Headquarters Basel, Switzerland Key people Daniel Vasella (Chairman of the board and CEO) Industry Pharmaceutical industry Products Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health (list...) Revenue US $44.27 billion (2009)[1] Operating income ▲ US $9.98 billion (2009)[1] Net income ▲ US $8.40 billion (2009)[1] Employees 99,830 (FTE, 2009)[1] Subsidiaries Ciba Vision, Sandoz Website www.novartis. com
|
|
No comments:
Post a Comment